Tag: OTCQB:KALTF

August 22, 2019

Kalytera Announces Management-Led Private Placement of Up To $1.5 Million of Common Shares and Common Share Purchase Warrants

Kalytera Therapeutics, Inc. (TSXV:KLY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it intends to raise up to approximately CDN...
August 19, 2019

Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study

Kalytera Therapeutics, Inc. (TSXV:KLY and OTCQB:KALTF) (the "Company" or "Kalytera") today announced that interim results from the Company’s Phase 2...
May 21, 2019

Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF)(the "Company" or "Kalytera") has engaged Echelon Wealth Partners to determine the value, on a risk-adjusted...
April 17, 2019

Kalytera Therapeutics Announces Filing of Short Form Prospectus

Kalytera Therapeutics, Inc. (the “Company”, or “Kalytera”) (TSXV:KALY) (OTCQB:KALTF) announced today that it has filed a final short form prospectus...
February 5, 2019

Kalytera Reports Additional Positive Data for CBD in Prevention of Acute GVHD

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced additional positive interim data from its ongoing Phase 2...
January 31, 2019

Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has elected to issue 13,085,677 common...
January 23, 2019

Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the “Company” or “Kalytera”) is pleased to announce the closing of its private placement previously...